AMPD1 gene mutations are associated with obesity and diabetes in polish patients with cardiovascular diseases

Journal of Applied Genetics

Volumn 52, Issue 1, 2011, Pages 67-76

  Safranow, Krzysztof ^a   Suchy, Janina ^a   Jakubowska, Katarzyna ^a   Olszewska, Maria ^a   Bińczak Kuleta, Agnieszka ^a   Kurzawski, Grzegorz ^a   Rzeuski, Ryszard ^a   Czyżycka, Edyta ^a   Łoniewska, Beata ^a   Kornacewicz Jach, Zdzisława ^a   Ciechanowicz, Andrzej ^a   Chlubek, Dariusz ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

AMP deaminase 1; Coronary artery disease; Denaturing high performance liquid chromatography; Diabetes; Heart failure; Human genetics; Obesity

Indexed keywords

EID: 79955031847     PISSN: 12341983     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13353-010-0009-x     Document Type: Article

References (43)

1. Agresti A (1992) A survey of exact inference for contingency tables. Stat Sci 7:131-177
2. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25:3389-3402
3. Anderson JL, Habashi J, Carlquist JF, Muhlestein JB, Horne BD, Bair TL, Pearson RR, Hart N (2000) A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease. J Am Coll Cardiol 36:1248-1252
4. Andreassi MG, Botto N, Laghi-Pasini F, Manfredi S, Ghelarducci B, Farneti A, Solinas M, Biagini A, Picano E (2005) AMPD1 (C34T) polymorphism and clinical outcomes in patients undergoing myocardial revascularization. Int J Cardiol 101:191-195
5. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-65
6. Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR (2003) ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res 31:3568-3571
7. Clopper CJ, Pearson ES (1934) The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 26:404-413
8. Collins RP, Palmer BR, Pilbrow AP, Frampton CM, Troughton RW, Yandle TG, Skelton L, Richards AM, Cameron VA (2006) Evaluation of AMPD1 C34T genotype as a predictor of mortality in heart failure and post-myocardial infarction patients. Am Heart J 152:312-320
9. de Groote P, Lamblin N, Helbecque N, Mouquet F, Hermant X, Amouyel P, Dallongeville J, Bauters C (2006) The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure: a study in 686 consecutive patients. Am Heart J 152:736-741
10. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486-2497
11. Fischer S, Drenckhahn C, Wolf C, Eschrich K, Kellermann S, Froster UG, Schober R (2005) Clinical significance and neuropathology of primary MADD in C34-T and G468-T mutations of the AMPD1 gene. Clin Neuropathol 24:77-85
12. Fischer H, Esbjörnsson M, Sabina RL, Strömberg A, Peyrard-Janvid M, Norman B (2007) AMP deaminase deficiency is associated with lower sprint cycling performance in healthy subjects. J Appl Physiol 103:315-322
13. Fishbein WN, Davis JI, Foellmer JW, Nieves S, Merezhinskaya N (1997) A competitive allele-specific oligomers polymerase chain reaction assay for the cis double mutation in AMPD1 that is the major cause of myo-adenylate deaminase deficiency. Mol Diagn 2:121-128
14. Frank B, Burwinkel B, Bermejo JL, Försti A, Hemminki K, Houlston R, Mangold E, Rahner N, Friedl W, Friedrichs N, Buettner R, Engel C, Loeffler M, Holinski-Feder E, Morak M, Keller G, Schackert HK, Krüger S, Goecke T, Moeslein G, Kloor M, Gebert J, Kunstmann E, Schulmann K, Rüschoff J, Propping P; German HNPCC Consortium (2008) Ten recently identified associations between nsSNPs and colorectal cancer could not be replicated in German families. Cancer Lett 271:153-157
15. Gastmann A, Sigusch HH, Henke A, Reinhardt D, Surber R, Gastmann O, Figulla HR (2004) Role of adenosine monophosphate deaminase-1 gene polymorphism in patients with congestive heart failure (influence on tumor necrosis factor-alpha level and outcome). Am J Cardiol 93:1260-1264
16. Gerbitz KD, Gempel K, Brdiczka D (1996) Mitochondria and diabetes. Genetic, biochemical, and clinical implications of the cellular energy circuit. Diabetes 45:113-126
17. Goodarzi MO, Taylor KD, Guo X, Quiñones MJ, Cui J, Li X, Hang T, Yang H, Holmes E, Hsueh WA, Olefsky J, Rotter JI (2005) Variation in the gene for muscle-specific AMP deaminase is associated with insulin clearance, a highly heritable trait. Diabetes 54:1222-1227
18. Gross M (1997) Clinical heterogeneity and molecular mechanisms in inborn muscle AMP deaminase deficiency. J Inherit Metab Dis 20:186-192
19. Gross M, Rötzer E, Kölle P, Mortier W, Reichmann H, Goebel HH, Lochmüller H, Pongratz D, Mahnke-Zizelman DK, Sabina RL (2002) A G468-T AMPD1 mutant allele contributes to the high incidence of myoadenylate deaminase deficiency in the Caucasian population. Neuromuscul Disord 12:558-565
20. Guo SW, Thompson EA (1992) Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 48:361-372
21. Han BW, Bingman CA, Mahnke DK, Bannen RM, Bednarek SY, Sabina RL, Phillips GN Jr (2006) Membrane association, mechanism of action, and structure of Arabidopsis embryonic factor 1 (FAC1). J Biol Chem 281:14939-14947
22. Hanisch F, Joshi P, Zierz S (2008) AMP deaminase deficiency in skeletal muscle is unlikely to be of clinical relevance. J Neurol 255:318-322
23. International HapMap Consortium (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature 449:851-861
24. Isackson PJ, Bujnicki H, Harding CO, Vladutiu GD (2005) Myoadenylate deaminase deficiency caused by alternative splicing due to a novel intronic mutation in the AMPD1 gene. Mol Genet Metab 86:250-256
25. Jones AC, Austin J, Hansen N, Hoogendoorn B, Oefner PJ, Cheadle JP, O'Donovan MC (1999) Optimal temperature selection for mutation detection by denaturing HPLC and comparison to single-stranded conformation polymorphism and heteroduplex analysis. Clin Chem 45:1133-1140
26. Karges B, LeHeup B, Schoenle E, Castro-Correia C, Fontoura M, Pfäffle R, Andler W, Debatin KM, Karges W (2004) Compound heterozygous and homozygous mutations of the TSHbeta gene as a cause of congenital central hypothyroidism in Europe. Horm Res 62:149-155
27. Kolek MJ, Carlquist JF, Thaneemit-Chen S, Lazzeroni LC, Whiting BM, Horne BD, Muhlestein JB, Lavori P, Anderson JL (2005) The role of a common adenosine monophosphate deaminase (AMPD)-1 polymorphism in outcomes of ischemic and nonischemic heart failure. J Card Fail 11:677-683
28. Kurzawski G, Safranow K, Suchy J, Chlubek D, Scott RJ, Lubiński J (2002) Mutation analysis of MLH1 and MSH2 genes performed by denaturing high-performance liquid chromatography. J Biochem Biophys Methods 51:89-100
29. Loh E, Rebbeck TR, Mahoney PD, DeNofrio D, Swain JL, Holmes EW (1999) Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure. Circulation 99:1422-1425
30. Mangani S, Benvenuti M, Moir AJ, Ranieri-Raggi M, Martini D, Sabbatini AR, Raggi A (2007) Characterization of the metallocenter of rabbit skeletal muscle AMP deaminase. Evidence for a dinuclear zinc site. Biochim Biophys Acta 1774:312-322
31. Martini D, Ranieri-Raggi M, Sabbatini AR, Moir AJ, Polizzi E, Mangani S, Raggi A (2007) Characterization of the metallocenter of rabbit skeletal muscle AMP deaminase. A new model for substrate interactions at a dinuclear cocatalytic Zn site. Biochim Biophys Acta 1774:1508-1518
32. Morisaki T, Sabina RL, Holmes EW (1990) Adenylate deaminase. A multigene family in humans and rats. J Biol Chem 265:11482-11486
33. Morisaki T, Gross M, Morisaki H, Pongratz D, Zöllner N, Holmes EW (1992) Molecular basis of AMP deaminase deficiency in skeletal muscle. Proc Natl Acad Sci USA 89:6457-6461
34. Morisaki H, Morisaki T, Newby LK, Holmes EW (1993) Alternative splicing: a mechanism for phenotypic rescue of a common inherited defect. J Clin Invest 91:2275-2280
35. Morisaki H, Higuchi I, Abe M, Osame M, Morisaki T (2000) First missense mutations (R388W and R425H) of AMPD1 accompanied with myopathy found in a Japanese patient. Hum Mutat 16:467-472
36. Norman B, Mahnke-Zizelman DK, Vallis A, Sabina RL (1998) Genetic and other determinants of AMP deaminase activity in healthy adult skeletal muscle. J Appl Physiol 85:1273-1278
37. Sabina RL, Swain JL, Patten BM, Ashizawa T, O'Brien WE, Holmes EW (1980) Disruption of the purine nucleotide cycle. A potential explanation for muscle dysfunction in myoadenylate deaminase deficiency. J Clin Invest 66:1419-1423
38. Sabina RL, Morisaki T, Clarke P, Eddy R, Shows TB, Morton CC, Holmes EW (1990) Characterization of the human and rat myoadenylate deaminase genes. J Biol Chem 265:9423-9433
39. Safranow K, Czyzycka E, Binczak-Kuleta A, Rzeuski R, Skowronek J, Wojtarowicz A, Jakubowska K, Olszewska M, Loniewska B, Kaliszczak R, Kornacewicz-Jach Z, Ciechanowicz A, Chlubek D (2009) Association of C34T AMPD1 gene polymorphism with features of metabolic syndrome in patients with coronary artery disease or heart failure. Scand J Clin Lab Invest 69:102-112
40. Toyama K, Morisaki H, Kitamura Y, Gross M, Tamura T, Nakahori Y, Vance JM, Speer M, Kamatani N, Morisaki T (2004) Haplotype analysis of human AMPD1 gene: origin of common mutant allele. J Med Genet 41:e74
41. Wang Z, Rolish ME, Yeo G, Tung V, Mawson M, Burge CB (2004) Systematic identification and analysis of exonic splicing silencers. Cell 119:831-845
42. Webb EL, Rudd MF, Sellick GS, El Galta R, Bethke L, Wood W, Fletcher O, Penegar S, Withey L, Qureshi M, Johnson N, Tomlinson I, Gray R, Peto J, Houlston RS (2006) Search for low penetrance alleles for colorectal cancer through a scan of 1467 non-synonymous SNPs in 2575 cases and 2707 controls with validation by kin-cohort analysis of 14 704 first-degree relatives. Hum Mol Genet 15:3263-3271
43. Yazaki Y, Muhlestein JB, Carlquist JF, Bair TL, Horne BD, Renlund DG, Anderson JL (2004) A common variant of the AMPD1 gene predicts improved survival in patients with ischemic left ventricular dysfunction. J Card Fail 10:316-320